IONIQ Sciences

07/25/2023

This is a Pioneer Day shoutout to the Utah delegation in DC and Gov Cox who we've met with regarding the proposed Multi-Cancer Early Detection Screening (MCED) in Congress. Thanks for working with us to improve MCED to ensure that it doesn't limit competition and innovation

07/21/2023

Evidence continues to reveal the need for a less expensive, non-radiating early detection test for breast cancer - one not compromised by dense breast tissue affecting 47% of women. That's why we're modernizing early-stage cancer detection. The IONIQ System shows prediction across breast types and in the earliest stages of the disease. This Health Affairs article does a great job outlining the problem: https://bit.ly/3O3P8zb Now check out our published solution: https://bit.ly/445ysOU

The US Preventive Services Task Force’s recent proposed guidelines on breast cancer screenings missed the mark on several issues—and must be reconsidered.

07/07/2023

Medtech Breakthrough has awarded IONIQ Sciences best diagnostic tech solution of the year 2023! Our mission is to "break through" the screening status quo to catch cancer early. That means no needles, no radiation, and no surgery - in just 20 minutes. https://bit.ly/44ufHEe

06/22/2023

We joined our friends at Black Physicians of Utah (BPOU) for a Juneteenth celebration of health and wellness! It was a great opportunity to recruit for our ongoing clinical trial supporting the early detection of cancer. Remember: anyone can participate and earn $100!

06/15/2023

After 3 years of being a key contributor to our success at IONIQ Sciences, we celebrated Natasha’s last day on our team. We're delighted to share she has been accepted to attend this fall. Please join us in wishing Natasha well! You’ll do great, Dr. Andreasen!

06/13/2023

Jared Bauer, IONIQ Sciences CEO, was interviewed on the Empowered Patient Podcast in their recent episode, “Using Bioimpedance-Based Technology for Early Detection of Cancer.” Jared’s conversation with hostess Karen Jagoda is an insightful exploration of bioimpedance in cancer detection, with an emphasis on what this means for patients.

Watch the full episode here: https://bit.ly/3MZ7r8h

Salt Lake City, UT, May 19, 2023 – We’re pleased to announce that Jared Bauer, IONIQ Sciences CEO, was interviewed on the Empowered Patient Podcast in their recent episode, “Using Bioimpedance-Based Technology for Early Detection of Cancer.” Mr. Bauer highlights the core technology of IONIQ....

06/05/2023

"If there was a test that could reassure people that a lesion was malignant or benign, that would be spectacular. It would cut costs, it would cut the risk to patients, and it would change the risk/benefit ratio for the early detection of lung cancer." John C. Ruckdeschel, MD. https://bit.ly/42tcYcO

05/30/2023

Jared Bauer , CEO, will present in-person at the 13th Annual LD Micro Invitational at the Luxe Sunset Boulevard Hotel in LA, CA on June 6-8, 2023. The event is expected to feature 150+ companies and consistently showcases the next generation of great companies. IONIQ Sciences is scheduled to present on June 7 at 2pm PT.

We invite interested parties to register to watch the presentation virtually here: https://bit.ly/3oqiHlN

05/17/2023

Our Medical Advisor, Dr. Raphael E. Po***ck, is the Director of Ohio State University Comprehensive Cancer Center and Professor Emeritus in the Department of Surgical Oncology at MD Anderson Cancer Center. As an award-winning surgical oncologist and physician researcher, he's co-authored more than 21 books and 400 original research and review articles!

05/10/2023

We're continuing our celebration of Cancer Research Month by highlighting our scientific advisor, Dr. Benjamin Haibe-Kains, who has 200 peer-reviewed scientific papers to his credit. He is also Senior Scientist at the Princess Margaret Cancer Centre and Associate Professor in the Medical Biophysics department of the University of Toronto. His research expertise is an essential component of our efforts to modernize early-stage cancer detection.

https://bit.ly/3NQHF8c

05/04/2023

In honor of National Cancer Research Month, we're looking back at powerful discoveries made in our Breast Feasibility Trial featured in IEEE peer reviewed scientific journal. Our research continues to draw on our discovery of separation between benign and malignant breast lesions measured with bioimpedance.

This is made possible by Dr. Benjamin Sanchez, one of our key scientific advisors and a world-renowned bioimpedance expert who has nearly 60 publications to his credit. He is helping accelerate our expansion from a single lung cancer test towards a Multi-Cancer Screen

Salt Lake City, UT, November 30, 2021 – In collaboration with two of our Scientific Advisors, IONIQ Sciences, Inc. (“IONIQ” or the “Company”), is proud to announce the prestigious IEEE Access peer-reviewed journal has published a scientific manuscript on the life-saving potential of our .....

05/01/2023

May is cancer research month. In developing the IONIQ ProLung Test, we've learned a lot about the world's deadliest cancer. Click the link to see how lung cancer accounts for 32% of cancer deaths but only receives 10% of research dollars. The upshot here is not to reduce research in other cancers, but broaden it generally - especially where the most lives can be saved

Ideally, the distribution of research funding for different types of cancer should be equitable with respect to the societal burden each type of cancer imposes. These burdens can be estimated in a variety of ways; “Years of Life Lost” ...